<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 5, 2000
Commission File Number 0-19606
AMERICAN BIOMED, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 76-0136574
(State of other jurisdiction of (I.R.S. Employer
Incorporation or organization) Identification No.)
14800 QUORUM DRIVE SUITE 200, DALLAS TEXAS 75240
(Address of principal executive office) (Zip Code)
(972)-308-8575
(Registrant's telephone number including area code)
<PAGE>
Item 5. RELOCATION OF CORPORATE HEADQUARTERS
Effective May 29th, 2000 the Company relocated its corporate headquarters.
The new mailing address is:
American BioMed, Inc.
14800 Quorum Drive, Suite 200
Dallas, Texas 75240
The new telephone number is:
972-308-8575
The new fax number is:
972-308-8578
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
American BioMed, Inc.
Date: June 5, 2000 By:/s/ Justine B. Corday
----------------------------------------
Name: Justine B. Corday
Title: Chairman of the Board and
Interim Chief Executive Officer
2
